Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

SA Pharmacy Medicines Information Service (COVID-19)

undefined

Your Questions, Our Responses

Medicines Information has received a number of COVID-19 related medicine enquiries. To facilitate knowledge sharing we are publishing our responses online. 

We will continually update this section with questions that are of relevance to healthcare professionals. 

Key Points:
> The Australian Government Department of Health has released a COVID-19 vaccination decision guide for women who are pregnancy, breastfeeding or planning a pregnancy.
> The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) has issued a statement regarding COVID-19 Vaccination in Pregnant and Breastfeeding Women.

The following international professional bodies have issued statements about the use of COVID-19 vaccines in pregnancy and breastfeeding:
> American College of Obstetricians and Gynecologists (ACOG)
> Academy of Breastfeeding Medicine (ABM)
> Centers for Disease Control and Prevention (CDC)
> Infant Risk Center
> Joint Committee on Vaccination and Immunisation (JCVI)
> Royal College of Obstetricians & Gynaecologists (RCOG)
> Society for Maternal Fetal Medicine (SMFM)

For further information contact SA Pharmacy Medicines Information.

Information is limited to a single article published as a pre-proof on 3/4/20 (see below).
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. 2020 Apr 3:104787.

Key Points:
> Ivermectin has been proposed as a treatment against SARS-CoV-2 through inhibition of nuclear transport activity.
> The investigators successfully demonstrated this inhibition in vitro.
> Currently, there is no evidence of its efficacy in humans or dosing for SARS-CoV-2.